Nicholas J. Singer

Insider Reports History

Reporting-owner location: Miami, FL
Latest reporting-owner signature: /s/ Nicholas J. Singer
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Nicholas J. Singer

Form 4 holding Director

Eterna Therapeutics Inc.

Security class: Common Stock
Shares / value: 266,214
Estimated value: $660,211
Report date: 02 Dec 2022
Price: $2.48
Ownership: By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer

Form 4 holding Director

Eterna Therapeutics Inc.

Security class: Common Stock
Shares / value: 121,822
Estimated value: $302,119
Report date: 02 Dec 2022
Price: $2.48
Ownership: By Purchase Capital LLC

Form 4 holding Director

Eterna Therapeutics Inc.

Security class: Warrants (right to buy)
Shares / value: 424,928
Estimated value
Report date: 02 Dec 2022
Price
Ownership: By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer
Underlying class: Common Stock, par value $0.005 per share
Underlying amount

Form 4 holding Chief Executive Officer, Director

OTR Acquisition Corp.

Security class: Class B Common Stock
Shares / value: 421,759
Estimated value
Report date: 20 May 2022
Price
Ownership: Indirect
Underlying class: Class A Common Stock
Underlying amount

Form 4 holding Director

Eterna Therapeutics Inc.

Security class: Warrants (right to buy)
Shares / value: 141,644
Estimated value
Report date: 02 Dec 2022
Price
Ownership: By Purchase Capital LLC
Underlying class: Common Stock, par value $0.005 per share
Underlying amount

Form 4 holding Chief Executive Officer, Director

OTR Acquisition Corp.

Security class: Class A Common Stock
Shares / value: 0
Estimated value
Report date: 20 May 2022
Price
Ownership: PC SPAC Holdings LLC

Form 4 holding Chief Executive Officer, Director

OTR Acquisition Corp.

Security class: Class B Common Stock
Shares / value: 0
Estimated value
Report date: 20 May 2022
Price
Ownership: PC SPAC Holdings LLC
Underlying class: Class A Common Stock
Underlying amount

Form 4 holding Chief Executive Officer, Director

OTR Acquisition Corp.

Security class: Warrants
Shares / value: 0
Estimated value
Report date: 20 May 2022
Price
Ownership: PC SPAC Holdings LLC
Underlying class: Class A Common Stock
Underlying amount

Insider Reports Filed by Nicholas J. Singer

4 ERNA

Eterna Therapeutics Inc.

Report period: 02 Dec 2022
Transactions: 4
Transaction value: +$1,000,000
Accepted by SEC: 06 Dec 2022, 17:52
Role: Director
Next action: Open filing details

4 ERNA

Brooklyn ImmunoTherapeutics, Inc.

Report period: 01 Aug 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 03 Aug 2022, 20:01
Role: Director
Next action: Open filing details

3 ERNA

Brooklyn ImmunoTherapeutics, Inc.

Report period: 05 Jun 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 07 Jun 2022, 21:08
Role: Director
Next action: Open filing details

4

OTR Acquisition Corp.

Report period: 20 May 2022
Transactions: 5
Transaction value: $0
Accepted by SEC: 20 May 2022, 16:35
Role: Chief Executive Officer, Director
Next action: Open filing details

4

OTR Acquisition Corp.

Report period: 06 May 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 10 May 2022, 08:52
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .